Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants
Clinical trial NCT06069895 · COMPLETED
Trial details
- NCT number
- NCT06069895
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2025-04-23
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.